Microbiological and Serological Evaluation of the Meningitis Outbreak in a Community Center in Isfahan Province, Iran, during the Years 2016-2017

Document Type : Original Article (s)

Authors

1 Associate Professor, Department of Social Medicine, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Infectious Disease Specialist, Center for Disease Control, Isfahan Province Health Center, Isfahan, Iran

3 Student of Medicine, Student Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

4 General Practitioner, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Meningococcal meningitis is a major health problem in tropical regions, including Iran. Identification of the type of serogroup involved in screening programs is essential. Therefore, the aim of this study was to investigate the microbiological and serological characteristics of meningitis outbreaks in a camp in Isfahan Province, during the years 2016-2017.Methods: This cross-sectional study performed on 51 patients with meningococcal meningitis. After recording the demographic data, various variables including history of vaccination and prophylaxis, lumbar puncture (LP) result, blood culture, and antibiotic resistance were recorded. The obtained statistics were reported as abundance and average.Findings: 31.4% of the subjects were vaccinated, and 76.5% had received a prophylaxis. In cerebrospinal fluid (CSF) culture, 80.48% of cases were negative, only 4.87% were streptococcus viridans, and 14.53% were Neisseria meningitides. In evaluating blood culture, 74.50% of cases were negative, 23.50% of cases were Neisseria meningitides, and 2.00% of cases were Staphylococcus epidermidis. All the serogroups were serogroup B.Conclusion: In our study, it was found that the incidence of meningitis was high even in patients who received standard prophylaxis and meningococcal vaccine. On the other hand, all of them had serogroup B; therefore preventive measures including the use of vaccines and prophylaxis affecting serogroup B should be performed more serious.

Keywords

References

  1. Archer BN, Chiu CK, Jayasinghe SH, Richmond PC, McVernon J, Lahra MM, et al. Epidemiology of invasive meningococcal B disease in Australia, 1999-2015: Priority populations for vaccination. Med J Aust 2017; 207(9): 382-7.
  2. Apicella MA. Meningococcal infection. In: Goldman L, Ausiello DA, editors. Cecil textbook of medicine. Philadelphia, PA: Saunders; 2004. p. 1818-23.
  3. Yameogo TM, Kyelem CG, Poda GEA, Sombie I, Ouedraogo MS, Millogo A. Meningitis epidemic: Assessment of surveillance and treatment of cases in the health centers of a Burkina Faso district. Bull SocPathol Exot 2011; 104(1): 68-73.
  4. World Health Organization. Situation update on meningitis C epidemic risk [Online]. [cited 2017 Dec 21]; Available from: URL: http://www.who.int/csr/disease/meningococcal/meningitis-c-epidemic-risk/en/
  5. Greenberg R, Daniels S, Flanders W, Eley J, Boring J. Medical epidemiology. New York, NY: McGraw-Hill Education; 2012.
  6. Greenwood B M. Acute bacterial meningitis. In: Hunter GW, Strickland GT, editors. Hunter's tropical medicine and emerging infectious diseases. 8th ed. Philadelphia, PA: Saunders; 2000. p. 372-8.
  7. Houri H, Pormohammad A, Riahi SM, Nasiri MJ, Fallah F, Dabiri H, et al. Acute bacterial meningitis in Iran: Systematic review and meta-analysis. PLoS One 2017; 12(2): e0169617.
  8. World Health Organization. Meningococcal disease – Niger (update) [Online]. [cited 2015 Jul 23]. Available from: URL: http://www.who.int/csr/don/23-july-2015-niger/en/
  9. Burki T. Meningitis outbreak in Niger is an urgent warning. Lancet Infect Dis 2015; 15(9): 1011.
  10. Heydari B, Khalili H, Karimzadeh I, Emadi-Kochak H. Clinical, paraclinical, and antimicrobial resistance features of community-acquired acute bacterial meningitis at a large infectious diseases ward in Tehran, Iran. Iran J Pharm Res 2016; 15(1): 347-54.
  11. Mandal S, Wu HM, MacNeil JR, Machesky K, Garcia J, Plikaytis BD, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the United States. Clin Infect Dis 2013; 57(3): 344-8.
  12. Infectious Diseases Society of America. Notice to Healthcare Providers: Recognizing and Reporting Serogroup B Meningococcal Disease Associated with Outbreaks at Princeton University and the University of California at Santa Barbara [Online]. [cited 2018]; Available from: URL: http://www.idsociety.org/Princeton_UCSantaBarbara/
  13. Biswas HH, Han GS, Wendorf K, Winter K, Zipprich J, Perti T, et al. Notes from the Field: Outbreak of Serogroup B Meningococcal Disease at a University - California, 2016. MMWR Morb Mortal Wkly Rep 2016; 65(20): 520-1.
  14. Sridhar S, Greenwood B, Head C, Plotkin SA, Safadi MA, Saha S, et al. Global incidence of serogroup B invasive meningococcal disease: a systematic review. Lancet Infect Dis 2015; 15(11): 1334-46.
  15. Cohn AC, MacNeil JR, Clark TA, Ortega-Sanchez IR, Briere EZ, Meissner HC, et al. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2013; 62(RR-2): 1-28.
  16. World Health Organization. Meningococcal meningitis [Online]. [cited 2018 Jan]; Available from: URL: http://www.who.int/mediacentre/factsheets/fs141/en/
Journal of Isfahan Medical School
Volume 36, Issue 465 - Serial Number 465
January and February 2018
Pages 28-34

Files

History

  • Receive Date: 23 January 2018
  • Revise Date: 23 May 2024
  • Accept Date: 06 April 2022

Share

How to cite

Statistics